CAN FITE BIOPHARMA LTD-ADR (CANF) Stock Price & Overview
NYSEARCA:CANF • US13471N3008
Current stock price
The current stock price of CANF is 3.6 USD. Today CANF is down by -3.23%. In the past month the price decreased by -16.67%. In the past year, price decreased by -88.96%.
CANF Key Statistics
- Market Cap
- 4.713M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -9.44
- Dividend Yield
- N/A
CANF Stock Performance
CANF Stock Chart
CANF Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CANF. When comparing the yearly performance of all stocks, CANF is a bad performer in the overall market: 96.91% of all stocks are doing better.
CANF Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CANF. The financial health of CANF is average, but there are quite some concerns on its profitability.
CANF Earnings
CANF Forecast & Estimates
CANF Groups
Sector & Classification
CANF Financial Highlights
Over the last trailing twelve months CANF reported a non-GAAP Earnings per Share(EPS) of -9.44. The EPS increased by 39.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -102.07% | ||
| ROE | -188.34% | ||
| Debt/Equity | 0 |
CANF Ownership
CANF Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.8 | 398.492B | ||
| AMGN | AMGEN INC | 16.04 | 198.265B | ||
| GILD | GILEAD SCIENCES INC | 16.4 | 180.267B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.21 | 121.459B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.95 | 78.932B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.01 | 42.071B | ||
| INSM | INSMED INC | N/A | 30.073B | ||
| BIIB | BIOGEN INC | 11.29 | 27.136B | ||
| NTRA | NATERA INC | N/A | 26.973B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.95 | 23.353B | ||
| MRNA | MODERNA INC | N/A | 21.086B | ||
| EXAS | EXACT SCIENCES CORP | 340.74 | 19.713B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 18.84B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CANF
Company Profile
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The firm co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Company Info
IPO: 2005-09-22
CAN FITE BIOPHARMA LTD-ADR
10 Bareket Street, Kiryat Matalon, P.O. Box 7537
Petah Tikva 4951778 IL
CEO: Pnina Fishman
Employees: 5
Phone: 97239241114
CAN FITE BIOPHARMA LTD-ADR / CANF FAQ
Can you describe the business of CAN FITE BIOPHARMA LTD-ADR?
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The firm co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
What is the stock price of CAN FITE BIOPHARMA LTD-ADR today?
The current stock price of CANF is 3.6 USD. The price decreased by -3.23% in the last trading session.
What is the dividend status of CAN FITE BIOPHARMA LTD-ADR?
CANF does not pay a dividend.
How is the ChartMill rating for CAN FITE BIOPHARMA LTD-ADR?
CANF has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the market capitalization of CANF stock?
CAN FITE BIOPHARMA LTD-ADR (CANF) has a market capitalization of 4.71M USD. This makes CANF a Nano Cap stock.
What is the Short Interest ratio of CAN FITE BIOPHARMA LTD-ADR (CANF) stock?
The outstanding short interest for CAN FITE BIOPHARMA LTD-ADR (CANF) is 6.89% of its float.